Answers are grounded in this paper and cite their sources.
Machine learning uncovers impacts of gene polymorphisms on COVID-19 severity, indicating genetic risk factors.
The genetic background influences the outcomes of COVID-19. This study aimed to evaluate the incidence of polymorphisms in genes linked to the RAAS system, cytokine production, and vitamin D on COVID-19 severity, with the goal of gaining a deeper understanding of the genetic etiology related to COVID-19. This study involved 338 COVID-19 patients and employed machine learning methods to identify the genetic variants that most significantly affect COVID-19 severity. The results revealed that polymorphisms in the IL6, IL6R, IL1α, IL1R, IFNγ, TNFα, CRP, VDR, VDBP, and ACE2 genes are the most significant genetic factors influencing COVID-19 prognosis, particularly in terms of the risks of COVID-19 pneumonia, mortality, rehospitalization, and associated mortality. The machine learning methods achieved an AUC of 0.86 for predicting COVID-19 pneumonia, mortality, and mortality related to rehospitalization, as well as an AUC of 0.85 for rehospitalization within the first year. These results confirm the crucial role of genetic background in COVID-19 prognosis, facilitating the identification of patients at increased risk. In summary, this research demonstrates that genetics-driven machine learning models can pinpoint patients at heightened risk by primarily focusing on genetic variants associated with ACE2, inflammation, and vitamin D.
No takes yet. Share an insight, caveat, or question.
Jaurrieta-Largo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: